PATH
Menu

This issue of Outlook provides evidence-based information on the emerging use of misoprostol in obstetrics and gynecology. It describes current research, regulatory issues, availability, and administration, as well as misoprostol's use during labor and delivery for labor induction and for prevention and treatment of postpartum hemorrhage. It also describes its use in inducing or managing abortion, including for treatment of incomplete abortion, preabortion cervical ripening, and pregnancy termination. Finally, it outlines safety issues and implications for research and practice.

Author(s): Burns M

Corporate author(s): PATH

Publication date: April 2005

Available materials

English

Spanish

Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.

This publication is part of the series Outlook

Related regions: Global

See also:

For more information…

Contact: PATH Publications
Email: publications@path.org
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA